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ABSTRACT
The human EST1A/SMG6 polypeptide physically
interacts with the chromosome end replication
enzyme telomerase. In an attempt to better under-
stand hEST1A function, we have started to dissect
the molecular interactions between hEST1A and
telomerase. Here, we demonstrate that the interac-
tion between hEST1A and telomerase is mediated
by protein–RNA and protein–protein contacts.
We identify a domain within hEST1A that binds the
telomerase RNA moiety hTR while full-length
hEST1A establishes in addition RNase-resistant
and hTR-independent protein–protein contacts
with the human telomerase reverse transcriptase
polypeptide (TERT). Conversely, within hTERT, we
identify a hEST1A interaction domain, which com-
prises hTR-binding activity and RNA-independent
hEST1A-binding activity. Purified, recombinant
hEST1A binds the telomerase RNA moiety (hTR)
with high affinity (apparent overall Kd = 25nM) but
low specificity. We propose that hEST1A assembles
specifically with telomerase in the context of the
hTR–hTERT ribonucleoprotein, through the high
affinity of hEST1A for hTR and specific protein–
protein contacts with hTERT.
INTRODUCTION
Human EST1A/SMG6 (below referred to as hEST1A),
EST1B/SMG5 and EST1C/SMG7 were identiﬁed through
their sequence similarity with the Saccharomyces cerevisiae
Ever Shorter Telomeres 1 (Est1) gene product and
the Caenorhabditis elegans and Drosophila melanogaster
nonsense-mediated mRNA decay (NMD) factors
CeSMG5, CeSMG6 and CeSMG7 and DmSMG5 and
DmSMG6 (1–3). NMD leads to rapid decay of mRNAs
that carry premature stop codons. Immunoprecipitation
experiments using antibodies raised against hEST1A
and hEST1B revealed association of these polypeptides
with telomerase activity (1,2). We could not detect
association between hEST1C/SMG7 and telomerase in
co-immunoprecipitation experiments (Nele Hug and
J. Lingner, unpublished data). Telomerase association
is particularly evident for hEST1A, which appears to
associate with 70% of active telomerase aﬃnity puriﬁed
from HeLa cell extracts. Consistent with a direct function
of hEST1A at telomeres is its detection at telomeres in vivo
by chromatin immunoprecipitation (Claus Azzalin and
J. Lingner, manuscript submitted for publication).
Over-expression of hEST1A in the human ﬁbrosarcoma-
derived cell line HT1080 induces telomere–telomere
associations causing chromosome bridges during ana-
phase and a rapid apoptotic response (1). Telomeric
fusions in hEST1A-over-expressing cells may stem from
telomere uncapping followed by DNA break repair,
reminiscent of the loss of function phenotype of the
double strand telomere-binding protein TRF2 (4,5).
Thus, we hypothesize that endogenous hEST1A is
involved in modulating the telomere structure. Over-
expression of full-length hEST1A in kidney 293T cells
leads to progressive telomere shortening (2). This eﬀect
could be reversed by co-expression of telomerase reverse
transcriptase (TERT), suggesting that the shortening
depends on modulation of telomerase. Thus, hEST1A
may also regulate telomere length. In the yeasts
S. cerevisiae and Schizosaccharomyces pombe, the EST1
genes are required for telomerase-mediated telomere
elongation in vivo (6,7). S. cerevisiae Est1p recruits
telomerase to chromosome 30 ends through a direct
physical interaction with the telomere end-binding protein
Cdc13 (8). It is unknown if the human EST1-proteins play
a similar essential role for telomerase activation at
chromosome ends.
The involvement of human EST1A-C/SMG5-7 in
NMD has been substantiated in knock-down experiments,
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which leads to an increase in abundance of NMD-reporter
constructs carrying premature stop codons, and of
endogenous mRNAs that are regulated by this pathway
(9). Worm SMG5-7 are involved in the PP2A-mediated
dephosphorylation of UPF1, a highly conserved 50 to 30
helicase playing a central role in NMD (10,11) and
genome stability [(12); (see below)]. SiRNA-mediated
depletion of human EST1A-C/SMG5-7 leads to impair-
ment of NMD and accumulation of hyperphosphorylated
UPF1, over-expression of hEST1A/SMG6 promotes
dephosphorylation of UPF1 and hEST1B/SMG5 and
hEST1C/SMG7 are found in complexes with phospho-
UPF1 (3,10). Thus, the role of SMG5-7 proteins in the
phosphorylation cycle of UPF1 appear to be conserved
between worms and humans.
The above studies suggest that human EST1-
polypeptides may have dual functions in telomere main-
tenance and RNA surveillance pathways. Indeed, an
intimate relation between genome and RNA surveillance
pathways is also suggested by the ﬁndings that the human
phosphoinositide 3-kinase-related protein kinase (PIKK)
SMG1 is required for optimal activation of p53 upon
genotoxic stress (13). Also UPF1 is required for genome
stability (12). Depletion of UPF1 causes human cells to
arrest early in S-phase inducing an ATR-dependent DNA
damage response. A fraction of UPF1 associates with
chromatin in S-phase and upon g-irradiation, supporting
a direct role in genome stability. In contrast, down-
regulation of the NMD factor UPF2 does not interfere
with cell cycle progression and DNA stability, supporting
the notion that eﬀects on genome stability are not due
to a general loss in NMD and that only some NMD
factors play a role in genome stability (14). Towards an
attempt to understand the putative roles of hEST1A
in telomere/genome stability and RNA surveillance
pathways, we identify here functional domains of
hEST1A that mediate the interaction with telomerase.
We identify a high aﬃnity RNA-binding domain in
hEST1A and detect RNA-independent protein–protein
interactions that mediate assembly with telomerase.
We also identify a segment within the N-terminal part of
hTERT, which enables association with hEST1A.
MATERIALS AND METHODS
Protein expression and purification
A GST-tag encoding DNA fragment was ampliﬁed
by PCR from the pGEX-6P1 vector (GE Healthcare)
and subcloned in the pFastBac vector (Invitrogen).
A DNA fragment encoding the complete open reading
frame (1419 amino acids) of Homo sapiens EST1A
(SMG6, KIAA0732) was subcloned in frame downstream
of the GST-tag in the modiﬁed pFastBac vector.
Baculoviruses were prepared following the manual of the
Bac-to-Bac Baculovirus expression system (Invitrogen).
Hi5 insect cells were transduced with baculoviruses at
m.o.i. of 20. Forty-eight hour post-infection, nuclear
extracts were prepared as described (15) with slight
modiﬁcations. Infected Hi5 cell pellets harvested from
135mm plates (1.5 107 cells before infection)
were resuspended in 5.75ml of cold buﬀer A (50mM
Tris–HCl pH 8.0, 100mM KCl, 0.1mM PMSF, 0.1mM
EDTA, 0.1mM DTT, 0.3% NP40) and kept on ice for
15–20min for cell lysis. After centrifugation for 5min at
500g at 48C, the nuclei containing pellet was washed three
times with 1ml buﬀer A, repeating in between the
centrifugation step. For extraction, the washed nuclei
were resuspended in 0.75ml of cold buﬀer B (50mM
Tris–HCl pH 8.0, 400mM NaCl, 1mM EGTA, 1mM
EDTA, 1mM DTT, 1mM PMSF, protease cocktail
inhibitor EDTA-free from Roche), transferred in a
microfuge tube and shaken very gently for 30min at
48C. The mixture was centrifuged for 5min with maximal
velocity at 48C. Tween 20 and glycerol were added to
ﬁnal concentrations of 0.2 and 10%, respectively, to the
nuclear extract corresponding supernatant. 0.21ml slurry
of glutathione-Sepharose beads (GE Healthcare) were
washed with cold 1 PBS and equilibrated with buﬀer B
supplemented with 0.2% Tween 20 and 10% glycerol.
The nuclear extract was added to these beads and
incubated at 48C for 1.5 h on a wheel. The ﬂow through
was collected upon centrifugation for 1min at 500g at 48C.
The beads were washed three times with 1.5ml of cold
EB buﬀer (100mM Tris–HCl pH 8.0, 400mM NaCl, 10%
glycerol, 0.2% Tween 20, 1mM DTT, 1mM EDTA and
protease cocktail inhibitor EDTA-free). GST–hEST1A
was eluted from the beads with 0.21ml of cold GEB buﬀer
(buﬀer EB containing 20mM GSH) after incubation at
48C for 45min on a wheel. The recovered supernatant
was applied to a small disposable ﬁlter column (Biorad)
to remove the remaining beads. The elution step was
repeated two more times for 15min. Upon puriﬁcation,
the GST–hEST1A polypeptide was estimated to be more
than 90% pure. As negative control, nuclear extracts of
Hi5 cells that had been infected with baculoviruses
containing only the GST transgene were prepared and
puriﬁed following the same procedure.
Plasmids
DNA fragments encoding for the hTR deletion mutants
downstream of a T7 promoter were generated by PCR
(Pseudo and Pseudo) or overlap extension PCR
(CR45; see Ref. (16) for the method) using pT7hTER
(17) as a template.
hEST1A deletion mutants (1–855), (1–457), (1–237),
(606–1419), (783–1419), (606–991) and (606–855) were
generated by DNA restriction and ligation of DNA
fragments into pcDNA6myc-HisC (Invitrogen) or by
ligation into a modiﬁed phrGFP-N1 vector (Stratagene)
in which a FLAG encoding sequence was used to replace
the GFP sequence. In these vectors, expression is driven
by the CMV promoter and polyadenylation is triggered by
the SV40 poly(A) site. Mutant (243–533) was generated
by PCR ampliﬁcation of the respective hEST1A
fragment and subcloning into pcDNA6myc-HisC.
Mutant (243–412) was generated by overlap extension
PCR (16) and subcloning into pcDNA6myc-HisC.
hTERT deletion mutants (1–832), (1–656) and (1–446)
were generated by DNA restriction and ligation
in pcDNA6myc-HisC-hTERT (18). All the other
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hTERT-mutants were generated from pcDNA6myc-
HisC-hTERT using a site-directed mutagenesis kit
(Stratagene). Further details on plasmid constructions
can be obtained upon request.
RNA band shifts
RNAs were transcribed in vitro following the instructions
of the Ribomax large-scale RNA production system-T7
kit (Promega). After in vitro transcription, DNA
templates were removed by DNase I digestion and the
RNA samples were extracted with phenol:chloroform
(1:1) and precipitated with ethanol. Analysis of the RNA
samples by gel electrophoresis conﬁrmed their correct
length and intactness. Full-length hTR was prepared as
described (17) and gel puriﬁed. Transcribed hTR was
dephosphorylated at the 50 end with CIP (Roche)
and extracted with phenol:chloroform (1:1). hTR was
50-end labeled with [32P]-g-ATP using T4 polynucleotide
kinase and unincorporated nucleotides were removed
using mini quick spin RNA columns (Roche).
Ribosomal RNA was gel puriﬁed from total RNA of
HeLa cells prepared with the RNA easy kit (Qiagen).
Escherichia coli tRNA was from Roche. RNA–protein
complexes were separated on native 3.5% polyacrylamide/
0.4% agarose gels that were run in 75mM Tris–glycine
buﬀer at 48C (150V for 30min followed by 300V for 3 h).
The gels were pre-run for 1 h at 250V.
For the determination of the overall Kd of GST–
hEST1A for hTR, GST–hEST1A (1–100 nM) was incu-
bated with 1 nM 50 [32P]-labeled hTR (hTR) in presence
of a 250 excess of tRNA as a non-speciﬁc competitor
in 70mM Tris–HCl pH 8.0, 80mM NaCl, 4mM GSH,
1.2mM EDTA, 1mM DTT and 4% glycerol for 30min at
RT. Time-course experiments with 1 nM 50 [32P]-labeled
hTR and 100 nM GST–hEST1A showed that the
binding equilibrium was reached already after <1min of
incubation. For the competition experiments, competitor
RNAs were added as indicated prior to addition of
hEST1A. Prior to loading on the gel, 1 ml of 20% Ficoll
was added. Competition experiments were quantiﬁed
from three independent reactions.
Pull-down experiments of telomerase and quantification
of the activity
1 ml of reconstituted and aﬃnity puriﬁed telomerase
from insect cells (17) or in rabbit reticulocyte lysates
(RRL) (Promega) reconstituted telomerase (19) was
incubated with 0.5 pmol of puriﬁed GST–hEST1A or
GST for 1 h at 48C in 10 ml ﬁnal volume of 20mM HEPES
pH 7.9, 100mM KCl, 1mM DTT, 10% glycerol and
0.2% Tween 20. 9 ml of this mixture was added to 36 ml of
30% slurry of GSH-Sepharose beads (GE Healthcare) in
IP buﬀer (20mM HEPES pH 7.9, 100mM KCl, 1mM
DTT, 10% glycerol, 0.2% Tween 20) and incubated 1 h at
48C on a wheel. The beads were washed three times with
150 ml of IP buﬀer. In Figure 1, telomerase activity was
measured by TRAP using quantitative PCR and the
light cycler (Roche) (18).
Transfection of human cell lines and immunoprecipitation
The 293T cells were transfected with 4 mg of total plasmid
DNA per well of a 6-well plate using Lipofectamine
2000 (Invitrogen). WI38-VA13 cells were transfected in
10 cm dishes with Lipofectamine 2000 (Invitrogen) as
recommended by the manufacturer. Twenty-four hours
post-transfection plasmid-containing cells were selected
with 4 mg/ml blasticidin for 48 h. Whole cell extracts were
prepared by resuspending cells in 600 ml of IPII
buﬀer (50mM HEPES pH 7.5, 140mM NaCl, 0.5%
TritonX-100), incubating the cell suspension for 30min
at 48C and centrifugating at 13 000 r.p.m. (16 100g)
for 10min. The supernatant was pre-cleared for 1 h at
Figure 1. Expression and puriﬁcation of recombinant GST–hEST1A protein and interaction with in vitro reconstituted telomerase. (A) SDS–PAGE
and Coomassie blue staining of GST–hEST1A fractions derived from Hi5 insect cells. Lane 1: MW: Molecular weight markers. Lane 2:
L: GST–hEST1A expressing Hi5 nuclear extract. Lane 3: FT: ﬂow through of GSH-beads. Lanes 4–6: E1, E2 and E3: ﬁrst, second and third eluates,
Lanes 7–10: BSA dilutions. GST–hEST1A is indicated. (B) Western blots with anti-GST and anti-hEST1A antibodies. (C) Relative TRAP activity
(%) pulled down with GSH-beads upon incubation of 50 nM GST (white rectangles) or 50 nM GST–hEST1A (fraction E1; black rectangles)
with telomerase reconstituted in vitro in insect cell lysates (Baculovirus) or in RRL. Interaction of GST–hEST1A and GST with telomerase in vitro.
Bars represent the means SD of three independent experiments.
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48C with protein A beads (GE Healthcare) and then
incubated with 1 mg/ml of either a-Myc (9B11 from NEB)
or a-FLAG (M2 from Sigma) antibodies for 1 h at 48C.
20 ml of a 50% slurry of protein A beads was added and
incubated over-night at 48C. Beads were recovered by
spinning 1min at 6500 r.p.m. (4000g) and washed ﬁve
times in the IPII buﬀer. Samples were loaded on 4–20%
gradient Tris–HCl PAGE duramide gels (Cambrex). After
semi dry transfer and western blotting, the signals were
measured using the ChemiGlow (Wytec) substrate on a
FluorChemTM 8900 machine (Alpha Innotech).
Immunoprecipitation in rabbit reticulocyte lysate
Myc-hTERT fragments and Flag-hEST1A fragments
were in vitro translated in the presence of [35S]-methionine
in RRL following the instructions of TnT quick-coupled
transcription/translation system (Promega). A total of
110ml of RRL-mix containing 88 ml of TNT T7 master
mix, 4.4 ml [35S]-methionine (1000Ci/mmol, 10mCi/ml)
and 440 ng plasmid DNA was incubated for 1.5 h at 308C.
Protein A beads were ﬁrst washed with 1 PBS and
then with IPIII buﬀer [20mM HEPES pH 7.5, 150mM
NaCl, 10% glycerol, 0.2% Tween 20, 0.4U/ml
RNAguardTM (GE Healthcare) and protease cocktail
inhibitor (EDTA-free, Roche)] and then blocked for 1 h at
48C in 1ml of IPIII buﬀer supplemented with 100 mg
E. coli tRNA and 500 mg BSA (NEB). The pre-blocked
beads were resuspended in IPIII buﬀer to give a 50%
slurry. For each immunoprecipitation, 1 mg of either
a-Myc (9B11 from NEB) or a-FLAG (M2 from Sigma)
antibodies were pre-incubated for 2.5 h at 48C with 20 ml
of 50% slurry of protein A beads (GE Healthcare) in IPIII
buﬀer. For hTR-binding experiments, 1 ml of [32P]-labeled
hTR (0.1 pmol/ml), 1 ml of non-labeled hTR (0.4 pmol/ml)
and 62.5 mg E. coli tRNA were mixed with 12.5 ml of
the RRL-mix to give a ﬁnal volume of 15.75 ml and
incubated 1 h at 308C. For pre-clearing, each reaction was
mixed with 20 ml of 50% slurry of protein A beads
(GE Healthcare) in IPIII buﬀer with 85 ml of IPIII buﬀer
for 1 h at 48C. The beads were removed by centrifugation
at 16 100g for 1.5min. Then the supernatant was
incubated for 2 h at 48C with 20 ml of the coated
protein A beads with the respective antibodies. After
immunoprecipitation, beads were recovered by
spinning 1min at 4000g and washed ﬁve times in 500 ml
IPIII buﬀer. Samples were loaded on 4–20% gradient
Tris–HCl PAGE duramide gels (Cambrex). After ﬁxation
following Cambrex instructions, gels were dried between
two cellophane sheets (GE Healthcare). [35S]-labeled
proteins and [32P]-labeled hTR were detected and
quantiﬁed on a PhosphoImager. [32P]-labeled hTR could
be distinguished from [35S]-labeled proteins by shielding
the lower energy [35S]-derived b-rays with a sheet
of plastic.
RESULTS
Recombinant hEST1A associates with active telomerase
To study the biochemical properties of hEST1A, we
expressed recombinant hEST1A as an N-terminal
glutathione (GST)-fusion protein from a baculoviral
vector in Hi5 insect cells. Nuclear extracts were prepared
and GST–hEST1A was puriﬁed on Sepharose-glutathione
beads (GSH-beads) (Figure 1). Analysis of column
eluates on Coomassie-brilliant blue stained polyacryla-
mide gels revealed one major band in the puriﬁed fraction
(Figure 1A), which was recognized on western blots by
GST-antibodies and hEST1A antibodies raised against
the full-length hEST1A (Figure 1B). This indicates
the presence of nearly homogeneously pure full-length
GST–hEST1A in the eluted fractions. To test the ability of
recombinant GST–hEST1A to associate with telomerase,
the puriﬁed protein was incubated with telomerase,
expressed and reconstituted in insect cells (17) or in
RRL (20). Upon binding of GST–hEST1A via its tag
to GSH-beads, the amount of associated telomerase
activity was determined in TRAP telomerase activity
assays, in which the products were quantiﬁed by real-time
PCR (Figure 1C). Ten to thirty percent of telomerase
activity associated with the beads in a GST–hEST1A-
dependent manner indicating eﬃcient association of
recombinant EST1A with telomerase. GST alone did not
bind substantial amounts of telomerase.
Recombinant hEST1A binds telomerase RNAwith
high affinity but low specificity
Association of hEST1A with telomerase may be mediated
by protein–protein and/or protein–RNA interactions.
In order to test the ability of hEST1A to bind the
telomerase RNA moiety hTR, RNA band shift experi-
ments were carried out (Figure 2). Increasing amounts
of GST–hEST1A were incubated with [32P]-50-end labeled
in vitro transcribed hTR. Separation of the fractions
on non-denaturing polyacrylamide gels indicated forma-
tion of slower migrating GST–hEST1A–hTR complexes
(Figure 2A). The experimental data for overall hEST1A–
hTR-binding ﬁtted best a theoretical curve with a Kd
of 25 nM (Figure 2A). The spread-out appearance of the
GST–hEST1A–hTR complexes may be due to conforma-
tional ﬂexibility, complex heterogeneity and concomitant
binding of several hEST1A polypeptides per hTR
molecule (see below). Thus this analysis gives an estimate
for the overall Kd of hEST1A–hTR complexes without
distinguishing individual subtypes. Other gel recipes,
removal of the GST-tag from hEST1A or the use of
hTR fragments did not reduce the heterogeneity. To test
binding aﬃnity for diﬀerent domains of hTR, diﬀerent
fragments of hTR were transcribed in vitro and tested
for their ability to inhibit the formation of the full-length
GST–hEST1A–hTR complex (Figure 2B). The -Pseudo
fragment had a similar capacity as unlabeled full-length
hTR, to compete for the formation of the [32P]-labeled
full-length GST–hEST1A–hTR complex (Figure 2B).
However, two other hTR fragments (Pseudo and
CR45) also competed well with hTR for hEST1A-
binding at slightly higher concentrations. Since the
three tested hTR fragments contained distinct non-
overlapping domains, this indicated several hEST1A–
hTR interaction sites. To further address speciﬁcity
of RNA binding, other non-related RNAs were tested in
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Figure 2. Recombinant GST–hEST1A interacts with hTR with high aﬃnity but low speciﬁcity. (A) EMSA analysis of [32P] 50-end labeled in vitro
transcribed hTR (hTR, 1 nM) with increasing amounts of puriﬁed GST–hEST1A (fraction E1). Lane 1: hTR alone. Lane 2: hTR incubated
in EMSA buﬀer. Lanes 3–12: hTR incubated with 0.83, 4.15, 8.3, 20.75, 33.2, 41.5, 53.95, 66.4, 83.0 and 166 nM of GST–hEST1A.
GST–hEST1A–hTR complexes are indicated. Right panel: Percentage of hTR bound to GST–hEST1A plotted as a function of the concentration
of GST–hEST1A. The experimental points ﬁtted well with a curve with a Kd of 25 nM. (B) EMSA competition experiment to identify GST–hEST1A-
binding speciﬁcity for diﬀerent hTR domains. The secondary structure models are schematically depicted. Lane 1: hTR alone. Lane 2: B:
hTR incubated with EMSA-buﬀer. Lanes 3–7: 50 nM GST–hEST1A (fraction E1) incubated with hTR and increasing molar equivalent of
unlabeled full-length hTR (5-, 10-, 50-, 100- and 500-fold excess). Lanes 8–13: 50 nM GST–hEST1A (fraction E1) incubated with hTR and
increasing molar equivalents of cold DCR45 (5-, 10-, 50-, 100-, 500- and 1000-fold excess). Lanes 14–19: 50 nM GST–hEST1A (fraction E1)
incubated with hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100-, 200- and 500-fold excess). Lanes 20–24: 50 nM GST–
hEST1A (fraction E1) incubated with hTR and increasing molar equivalent of cold Pseudo (5-, 10-, 50-, 100- and 500-fold excess). Right panel:
Quantiﬁcation of competition experiments. (C) EMSA competition experiment with additional RNA molecules. Lane 1: hTR incubated with EMSA
buﬀer. Lane 2: hTR incubated with 50 nM GST–hEST1A (fraction E1). Lanes 3–8: 50 nM GST–hEST1A (fraction E1) incubated with hTR
and increasing mass equivalents of cold full-length hTR (6.25-, 12.5-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Lanes 9–13: 50 nM
GST–hEST1A (fraction E1) incubated with hTR and increasing quantity of cold gel puriﬁed ribosomal RNA (rRNA) (6.25-, 12.5-, 25-, 62.5- and
100-fold mass excess over hTR). Lanes 14–17: 50 nM GST–hEST1A (fraction E1) incubated with hTR and increasing quantity of cold E. coli tRNA
(100-, 250-, 450- and 1800-fold mass excess over hTR). Lanes 18–23: 50 nM GST–hEST1A (fraction E1) incubated with hTR and increasing
quantity of heparin (6.25-, 12.25-, 25-, 62.5-, 100- and 250-fold mass excess over hTR). Right panel: quantiﬁcation of competition experiments.
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a competition experiment (Figure 2C). This experiment
indicated that the aﬃnity of hEST1A for rRNA is
similar as for hTR, while tRNA competes only at
20-fold higher concentration, indicating very low aﬃnity
of hEST1A for this RNA. Heparin eﬃciently inhibited
hTR binding.
Recombinant hEST1A has also been reported to
bind telomeric DNA oligonucleotides (2). However, the
RNA-binding domain of hEST1A appears distinct
from the DNA-binding domain. First, telomeric and
non-telomeric DNA oligonucleotides were not able to
compete with formation of the GST–hEST1A–hTR
complex even when present at a 1000-fold molar
excess (Supplementary Data, Figure 1). Second, the
DNA-binding domain of hEST1A has been mapped by
Lea Harrington’s laboratory (Toronto, personal
communication) to a fragment encompassing amino
acids 1–208 of hEST1A. This domain does not overlap
with the hTR-binding domain of hEST1A (TRID),
which has been mapped to amino acids 243–412 in the
next section.
Identification of the hTR-binding domain of hEST1A
To map the hEST1A domain that mediates hTR binding,
FLAG-hEST1A fragments (Figure 3A) were expressed
in RRL in presence of [35S]-methionine and incubated
with [32P]-labeled hTR. After immunoprecipitation of
FLAG-hEST1A with a-FLAG antibodies, samples were
separated by SDS–PAGE. [35S]-labeled proteins and
[32P]-labeled hTR were detected upon analysis on
a PhosphoImager (Figure 3B). [32P]-labeled hTR could
be unequivocally distinguished from [35S]-labeled proteins
by shielding the lower energy [35S]-derived b-rays with a
sheet of plastic (Figure 3B, lower part). In the absence
of the FLAG-epitope (lane hEST1A_FL), neither
hEST1A nor hTR was detected in the immunoprecipitate,
demonstrating the speciﬁcity of the assay for FLAG-
tagged hEST1A. A FLAG-hEST1A fragment encompass-
ing amino acids 243–412 immunoprecipitated hTR even
more eﬃciently than full-length FLAG-hEST1A, while
FLAG-hEST1A fragments lacking this domain did not
reveal eﬃcient hTR-binding activity (Figure 3C).
We therefore refer to this domain as hTR-interaction
domain (TRID).
TRID binds active telomerase
To map the hEST1A domain, which mediates association
with telomerase activity, FLAG-hEST1A fragments
were transiently expressed in 293T cells and FLAG-
hEST1A was immunoprecipitated with a-FLAG antibo-
dies. Expression of FLAG-hEST1A fragments and their
enrichment in the immunoprecipitate was tested in western
blots with a-FLAG antibodies (Figure 4A). Presence of
active telomerase was assessed in TRAP-assays
(Figure 4B). As expected, immunoprecipitation of telo-
merase activity depended on presence of the FLAG
epitope on hEST1A [Figure 4B, compare untagged
hEST1A (lanes 7–8) with FLAG-hEST1A (lanes 9–10)].
Again, the FLAG-hEST1A fragment encompassing
amino acids 243–412 was suﬃcient to immunoprecipitate
telomerase activity while FLAG-hEST1A fragments lack-
ing this domain immunoprecipitated considerably less
(fragment 606–991) or no telomerase activity (Figure 4B).
Thus, TRID is able to associate with active telomerase
probably via its association with hTR.
Identification of a hTERT fragment (EID) that
binds hEST1A and hTR
To identify a domain within hTERT that mediates
interaction with hEST1A, we transiently co-expressed
Myc-hTERT fragments with FLAG-hEST1A in 293T
cells (Figure 5). Extracts were prepared and FLAG-
hEST1A was immunoprecitated with a-FLAG antibodies.
Presence of FLAG-hEST1A in the immunoprecipitate
was checked in western blots with a-FLAG antibodies
and co-immunoprecipitated hTERT was detected with
a-Myc antibodies (Figure 5B). An hTERT fragment
encompassing amino acids 147–311 eﬃciently associated
with hEST1A and other hTERT fragments that
contained this domain also immunoprecipitated
FLAG-hEST1A. However, N-terminal fragments of
hTERT (1–144 or 1–78) did not immunoprecipitate
FLAG-hEST1A. We refer to the fragment encompassing
amino acids 147–311, which binds hEST1A as EID
(for hEST1A-interaction domain).
To test if hEST1A binding by hTERT involves also
hTR, we measured hTR-binding activity of diﬀerent
hTERT fragments. hTERT fragments were expressed in
presence of [35S]-methionine in RRL and incubated
with [32P]-labeled in vitro transcribed hTR (Figure 6).
After immunoprecipitation of Myc-hTERT with a-Myc
antibodies, samples were separated by SDS–PAGE.
[35S]-labeled proteins and [32P]-labeled hTR were detected
upon analysis on a PhosphoImager as in Figure 3. Weak
hTR-binding activities were detected with Myc-hTERT-
fragments containing amino acids 1–78, 1–144, 397–1132
and 707–1132. Most eﬃcient hTR-binding activity was
present in the EID-fragment (amino acids 147–311),
which also bound hEST1A in Figure 5.
Protein–RNA and protein–protein interactions mediate
association of human EST1A with hTERT
The above experiments delineated hEST1A and hTERT
domains that at the same time mediated the interaction
between hEST1A and hTERT as well as with hTR.
To test the hypothesis that the interaction between
hEST1A and hTERT was mediated by hTR, we transi-
ently co-expressed hEST1A and hTERT fragments in
293T cells and tested their interaction by co-immunopre-
cipitation upon treatment of the extracts with RNase A
(Figure 7). The extent of hTR destruction by RNase A
treatment was determined by assessing presence of
hTR upon Northern hybridization of dotblots with a
randomly labeled full-length hTR probe (Figure 7C).
Approximately 99% of the hTR signal disappeared in
extracts and more than 95% of the signal disappeared
in the immunoprecipitates upon RNase A treatment.
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Immunoprecipitated full-length FLAG-hEST1A
co-immunoprecipitated Myc-EID (hTERT-fragment
147–311) and this interaction was not alleviated upon
RNase A treatment (Figure 7A, compare lanes 5 and 6
on the right panel). Thus, while EID is able to bind
hTR it establishes also protein–protein contacts with
hEST1A. In contrast, when a TRID-containing FLAG-
hEST1A fragment [hEST1A-fragment (243–533)] was
immunoprecipitated, the interaction with EID was
RNase A sensitive (Figure 7A, compare lanes 7 and 8
on the right panel). Thus, EID cannot establish
stable protein–protein contacts with TRID as observed
with full-length hEST1A. Consistent with these results,
when either full-length Myc-hTERT or Myc-EID were
co-expressed with full-length FLAG-hEST1A and immu-
noprecipitated, FLAG-hEST1A remained associated
Figure 3. Identiﬁcation of the hEST1A hTR-binding domain (TRID). (A) Schematic representation of previously assigned hEST1A domains and
hEST1A truncations. EST1, EST1 homology domain; TPR, tetratricopeptide repeats; PIN, PilT amino-terminal domain (1). The EST1 and TPR
domains of the related SMG7/hEST1C form a 14-3-3 domain with a classic phosphoserine-binding pocket (31). For each polypeptide the association
with TRAP activity is indicated [determined in Figure 4; for hEST1A (1–855) association with TRAP activity is not shown (ns)]. TRID stands for
hTR Interacting Domain identiﬁed in B and C. (B) [32P] 50-end labeled in vitro transcribed hTR (hTR) was incubated with in RRL translated [35S]
methionine-labeled full-length hEST1A, full-length Flag-hEST1A (FL) and Flag-hEST1A fragments (amino acid fragments are indicated). After
immunoprecipitation with a-FLAG antibodies and ﬁve washes, samples were separated by 4–20% gradient SDS–PAGE. [35S] and [32P] signals were
revealed by analysis on a PhosphoImager. Upon placing a plastic ﬁlm between the gel and the PhosphoImager screen, only the [32P] signal was
detected (lower part). Filled black arrows indicate the presence of the polypeptide in the immunoprecipitated fractions and empty arrows indicate the
absence of the polypeptide. (C) Quantiﬁcation of hTR associated with Flag-hEST1A fragments based on the gel in panel B and at least two
additional experiments. The values were corrected by the immunoprecipitation eﬃciency of the individual polypeptides.
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with Myc-hTERT as well as with Myc-EID even upon
RNase A treatment of the beads after the immunopreci-
pitation (Figure 7B, compare in the right panel lanes
5 with 7 and lanes 9 with 11).
To further corroborate hTR-independent interactions
between hTERT and hEST1A, we assessed the interaction
between both polypeptides upon transient expression in
WI38-VA13, an immortal human ﬁbroblast cell line that
does not express hTR (Figure 7D). Again, Myc-hTERT
co-immunoprecipitated Flag-hEST1A (Figure 7D, left
panel) and Flag-hEST1A co-immunoprecipitated
Myc-hTERT and Myc-EID. This therefore conﬁrms
that full-length Myc-hTERT and Myc-EID interact with
hEST1A also in the absence of hTR via protein–protein
contacts.
DISCUSSION
Human EST1A was discovered through its sequence
similarity with S. cerevisiae Est1p but its precise function
at telomeres has remained unclear. We show here that
hEST1A associates with telomerase through dual
interactions with the telomerase RNA moiety and the
TERT. The TRID is contained within a 168 amino acid
fragment in the N-terminal part of hEST1A, a region
that does not contain any recognizable structural motifs
or sequence homologies with other proteins in the
database. TRID binds to hTR with high overall aﬃnity
(25 nM) but low speciﬁcity. Distinct non-overlapping
fragments of hTR as well as rRNA competed for binding
of full-length hTR with similar eﬃciency while tRNA was
a poor ligand for hEST1A. TRID is also distinct from
the DNA-binding domain of hEST1A (2), which resides
more N-terminal [amino acids 1–208, Lea Harrington’s
laboratory (Toronto, personal communication)].
Low speciﬁcity of RNA binding was also observed
in vitro with yeast Est1p, which displayed a similar aﬃnity
(50 nM) for the yeast telomerase RNA TLC1 and other
RNA substrates (21). However, in vivo a bulged stem of
TLC1, which has no obvious counterpart in human
telomerase RNA, mediates association with Est1p (22).
Thus, it is conceivable that similarly to yeast Est1p,
hEST1A also interacts with a speciﬁc hTR structure
in vivo in the context of the assembled hTR-hTERT
complex. This would be analogous to some ribosomal
proteins, which achieve RNA sequence-speciﬁc binding
only in the context of a partially assembled ribonucleo-
protein particle (23,24).
Consistent with this notion, we also identify
protein-mediated interactions between hEST1A and
TERT. TRID interacts with EID in a strictly RNA-
dependent manner whereas full-length hEST1A remains
associated with hTERT or with EID even upon digestion
of hTR with RNases, or when expressed in a cell line
that lacks hTR. Consistent with our results in cell culture,
telomerase RNA-independent association of hEST1A and
hTERT was observed in RRL (2). It remains to be
determined which domains outside of TRID establish
protein-mediated interactions with TERT. Interestingly,
the EST1/TPR domain of the hEST1A/SMG6-related
SMG7/hEST1C polypeptide has a 14-3-3 fold with
a classic phosphoserine-binding pocket (25). However,
other regions of the protein could also be involved.
We also identiﬁed a TERT domain that associates
with hEST1A. The EID is comprised between amino acids
147–311. EID contains hTR-binding activity and at the
same time it establishes RNase-resistant contacts
with hEST1A. Previous studies with hTERT have
identiﬁed two regions responsible for interactions with
TR, termed RNA interaction domain (RID) 1 and 2 (26).
The C-terminal part of RID1 (amino acids 1–250), which
associates with the hTR template-pseudoknot domain (27)
overlaps with the N-terminal part of EID (amino acids
147–311). A hTERT fragment containing the entire RID1
and EID regions did not pull-down more hTR than EID
on its own (Figure 6) suggesting that EID and RID1
contain one and the same RNA-binding domain.
Figure 4. Identiﬁcation of a hEST1A fragment that binds active
telomerase. The 293T cells were transiently transfected with expression
vectors for full-length EST1A, full-length Flag-hEST1A (FL) and
Flag-hEST1A fragments (amino acid fragments are indicated).
(A) Upon immunoprecipitation with a-FLAG antibodies and ﬁve
washes, samples were loaded on 4–20% gradient SDS–polyacrylamide
gels and FLAG-tagged EST1A fragments were revealed by western
blotting with a-FLAG antibodies. Input refers to extracts of the
transiently transfected 293T cells before immunoprecipitation.
(B) TRAP assay before and after immunoprecipitation with a-FLAG
antibodies. 3 and 1 refer to relative amounts of fraction used in
the assay.
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Figure 5. Identiﬁcation of an hTERT fragment (EID) that binds hEST1A. (A) Schematic representation of full-length hTERT and
hTERT fragments. The diﬀerent hTERT domains are indicated (32). For each polypeptide the molecular weight is given in kDa and the binding
of hEST1A as determined in B is indicated (+, binding; , no binding and ?, not known). (B) Transient co-expression in 293T cells of FLAG-
hEST1A and full-length hTERT, full length Myc-hTERT (FL) or Myc-hTERT fragments (amino acid numbers are indicated). FLAG-hEST1A
was immunoprecipitated using a-FLAG antibodies. Upon immunoprecipitation and ﬁve washes, samples were loaded on 4–20% gradient
SDS–polyacrylamide gels. The presence of Myc-hTERT fragments was determined by western blotting with a-Myc antibodies and the
immunoprecipitation eﬃciency was determined by western blotting with a-FLAG antibodies. The presence of the polypeptides is indicated by black
arrows whereas white arrows indicate absence of the polypeptides.
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However, deletion of residues 1–24 in RID1 abolished
binding of the template-pseudoknot domain (27), suggest-
ing that either the RNA-binding activity in EID is
distinct from RID1 or that the 1–25 RID1-mutant
displayed a folding problem that abolished RNA-binding
activity. Interestingly, the recently solved structure of
a Tetrahymena TERT region named TEN, which corre-
sponds to human RID1, shows a positively charged
ﬂexible C-terminal tail. This tail, which is present at
the N-terminus of EID has been proposed to be involved
in telomerase protein–RNA interactions (28). No func-
tions have been assigned before to the C-terminal part
of EID. Scanning mutagenesis with short linkers did not
identify hTERT-mutants in this region that abolished
telomerase function in vivo (29), but protein–protein
interactions may involve larger surfaces that were not
fully inactivated with this approach. Furthermore,
hEST1A–hTR interactions may partially compensate for
the loss of direct hTERT–hEST1A contacts.
The regulation of human telomerase at telomeres
and the putative role of hEST1A in this process are
poorly understood at the molecular level. The functional
analysis of hEST1A has been hampered by its involvement
in NMD (3) and essential roles of hEST1A for S-phase
progression presumably in conjunction UPF1 ((12) and
unpublished data). S. cerevisiae Est1p is thought to
mediate telomerase recruitment through its direct interac-
tion with Cdc13p, which binds to the telomeric 30
overhang (8). POT1, the putative human ortholog of
Cdc13p inhibits telomerase activity in vitro when bound to
the 30end of a telomeric oligonucleotide substrate (19,30).
Trials to detect a physical interaction between POT1 and
hEST1A have been unsuccessful so far and addition of
recombinant hEST1A to in vitro assays could also not
alleviate the inhibitory eﬀects of POT1 on telomerase
activity (our unpublished data). However, telomerase
recruitment by S. cerevisiae Cdc13p and Est1p has also
not yet been reproduced in vitro. The here reported
identiﬁcation and characterization of functional domains
of hEST1A that mediate interaction with telomerase may
allow to speciﬁcally disrupt these interactions to under-
stand the possible roles of hEST1A in telomere length
control and telomere capping.
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Figure 6. RNA-binding activity of hTERT fragments (see Figure 5A for schematic representation of the constructs). (A) [32P] 50-end labeled in vitro
transcribed hTR (hTR) was incubated with in RRL in presence of [35S] methionine translated full-length FLAG-hTERT, full-length Myc-hTERT
(FL) or Myc-hTERT fragments (amino acid numbers are indicated). Upon immunoprecipitation with a-Myc antibodies and ﬁve washes, samples
were loaded on 4–20% gradient SDS–polyacrylamide gels. The analysis was done as in Figure 3. (B) Quantiﬁcation of hTR associated (%) with the
Myc-hTERT fragments based on the gel in panel A and at least two additional experiments. The values were corrected by the immunoprecipitation
eﬃciency of the individual polypeptides.
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Figure 7. Protein–RNA and protein–protein interactions mediate association of human EST1A with hTERT. The indicated polypeptides were
transiently co-expressed in 293T (Figure 7A and B) or WI38-VA13 (Figure 7D) cells and immunoprecipitated (IP) with the indicated antibodies.
Polypeptides were revealed by western blotting with antibodies indicated on the left. (A) 293T cell extracts (600 ml) were either treated (+) or not
treated () with 3mg RNase A for 10min at 258C before starting the immunoprecipitation with a-FLAG antibody. After ﬁve washes, samples were
loaded on 4–20% gradient SDS–polyacrylamide gels. The presence of Myc-EID was determined by western blotting with a-Myc antibodies
and the immunoprecipitation eﬃciency was determined by western blotting with a-FLAG antibodies. (B) Transient co-transfection in 293T cells of
Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with a-Myc
antibodies. After ﬁve washes, the beads were either treated (+) or not treated () or with 0.5 mg RNase A/12 ml for 10min at 258C. The eluate
(E) was also analyzed to check for the release of Flag-hEST1A. The beads were washed one time before being loaded on 4–20% gradient
SDS–polyacrylamide gels. The presence of Flag-hEST1A was determined by western blotting with a-FLAG antibodies and the immunoprecipitation
eﬃciency was determined by western blotting with a-Myc antibodies. (C) Dot blot analysis of total RNA extracted from 293T cell extracts before
and after RNase A treatment, revealed with a randomly labeled full-length hTR probe. Extracts (Input) were treated with 0.005mg RNase A/ml
of extract and beads (IP) were treated with 0.04 mg of RNase A/ml of bead suspension as in B. (D) Transient co-transfection in WI38-VA13 cells of
Flag-hEST1A and full-length FLAG-hTERT, full-length Myc-hTERT (FL) and Myc-EID. Immunoprecipitations were carried out with a-Myc
antibodies (left panel) or a-Flag antibodies (right panel) as in A and B.
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